Best Practices, LLC just published a new research report on Advisory Board Management. The report examines how Advisory Boards at large, mid-cap, and small companies are able to organize, recruit and plan such critical product shaping think tanks. An effective

A quick peek behind the curtain at the Best Practices Research Center and a Most Interesting Case that recently landed on my desk. We are a consulting firm whose clients work mainly in the pharma and biotech sector. As a

Best Practices recently completed the second roundtable of our 2014-2015 Medical Affairs Consortium. The roundtable addressed the topic of “Medical Affairs Launch Support.” The roundtable brought together executives from 13 leading pharmaceutical organizations. Some exclusive key findings from the discussion

As many drugs are reaching the patent cliff, strategies to extend the commercial life of mature brands is critical to today’s pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as 10 years and billions of dollars to

Big Data has its roots in a set of statistical methods called econometrics A main feature of the finance, biology, and the social sciences is the apparent randomness of the behaviors being measured. Econometrics exists to distill the random and

We are past the peak of the Big Data hypecycle, not least of all because about half of the content on the topic put out by marketing gurus, branding experts, and other non-practitioners has moved on from extolling Big Data

As pharma companies plan for the launch of new products, much of the discussion centers around how to position a new drug or device to the rest of the world. Still, much of that same planning can be internalized and

Competitive Intelligence (CI) groups are instrumental in helping world-class companies to anticipate and respond strategically to external change. Primary and secondary competitive intelligence research helps organizations to improve their chances for success in today’s competitive business environment. While there are

Understanding how to fully deliver value within the Medical Affairs function is a challenge many leaders are facing. In today’s ever-changing healthcare landscape, leaders are constantly adjusting their budgets and outsourcing as the Medical Affairs function continues to grow in

In today’s tough economy, maintaining operational efficiencies remains key, even while focusing on strategy and tactics to drive growth and profitability. Commercial bio-pharma companies must also achieve challenging profitability rates in order to meet investor expectations. By understanding the best